RMQCX
Price
$336.71
Change
-$0.16 (-0.05%)
Updated
Apr 17 closing price
Net Assets
678.04M
RYAKX
Price
$43.15
Change
+$0.58 (+1.36%)
Updated
Apr 17 closing price
Net Assets
4.6M
Ad is loading...

RMQCX vs RYAKX

Header iconRMQCX vs RYAKX Comparison
Open Charts RMQCX vs RYAKXBanner chart's image
Rydex Monthly Rbl NASDAQ-100® 2x Strt C
Price$336.71
Change-$0.16 (-0.05%)
VolumeN/A
Net Assets678.04M
Rydex Russell 2000 1.5x Strategy A
Price$43.15
Change+$0.58 (+1.36%)
VolumeN/A
Net Assets4.6M
RMQCX vs RYAKX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMQCX vs. RYAKX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMQCX is a Hold and RYAKX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMQCX has more cash in the bank: 678M vs. RYAKX (4.6M). RYAKX pays higher dividends than RMQCX: RYAKX (1.51) vs RMQCX (0.31). RMQCX was incepted earlier than RYAKX: RMQCX (10 years) vs RYAKX (21 years). RMQCX (2.71) is less costly to investors than RYAKX (1.81). RMQCX is a more actively managed with annual turnover of: 334.00 vs. RYAKX (8.00). RMQCX (2500) and RYAKX (2500) have matching initial minimum investment requirements. RYAKX annual gain was more profitable for investors over the last year : -10.42 vs. RMQCX (-21.20). RMQCX return over 5 years is better than : 97.22 vs. RYAKX (1.36).
RMQCXRYAKXRMQCX / RYAKX
Total Expense Ratio2.171.71127%
Annual Report Gross Expense Ratio2.711.81150%
Fund Existence10 years21 years-
Gain YTD-26.721-24.854108%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets678M4.6M14,726%
Annual Yield % from dividends0.311.5121%
Returns for 1 year-21.20-10.42203%
Returns for 3 years-4.21-18.9922%
Returns for 5 years97.221.367,126%
Returns for 10 years533.31-26.47-2,015%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MECVX13.830.04
+0.29%
NYLI Epoch Capital Growth Investor Class
MSIQX10.43N/A
N/A
Morgan Stanley Inst International Eq I
AEYCX28.28N/A
N/A
American Century Equity Growth C
FOVCX19.80N/A
N/A
First Trust/Confluence Small Cap Val C
TGIHX13.17N/A
N/A
Nuveen Core Equity I